Key Market Indicators
Sales of digestive system disorder medicine in Iceland are expected to reach $30 million by 2026. The country recorded $26 million in sales in 2021, representing a 1.9% annual growth rate since 1985. Iceland currently ranks 28th in the world in terms of digestive system disorder medicine sales, with Luxembourg in the lead at $26 million. Japan, South Korea, and Canada ranked 2nd, 3rd and 4th, respectively.
